NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science
In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General
“Our Job Is to Be The One Agency That Speaks To Cancer”
“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”
NCABP “Anyone With Same Facts Would Have Come To Same Conclusion
Prevention Trial Could Stand On Its Own
Chabner : Opportunity To Set Own Agenda Reason For Leaving
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









